Premaitha Share Discussion Threads

[hjb1] 14/11/2016 14:21

certainly not doing themselves any favours..hope the courts are looking in!!

[toyboy1] 14/11/2016 14:13

Time for the EU to step in?

[timojelly] 14/11/2016 14:00

Illumina are a disgrace

[hurricane.] 13/11/2016 21:59

Premaitha to get test on University Hospitals of Leicester. It will initially cost £325 privately but will be potentially offered free of charge on the NHS for high risk women under government guidance and recommendation from 2017, so before the 2018 NHS implementation. Testing will commence post the 15th November 2016 for the East Midlands area as a whole and tests will be processed locally.

hxxp://www.leicestershospitals.nhs.uk/professionals/gp-education/introducing-nipt-to-uhl/

[andysand] 11/11/2016 09:42

It's way too early to judge NIPT, WSBN and especially CPT. I think KEFI is a loser though....

[tsmith2] 09/11/2016 16:48

hard cash versus hard of cash

[blackss] 09/11/2016 09:46

You are preaching to the converted dean.

[deanroberthunt] 09/11/2016 09:37

cpt BUY, DOWN
kefi BUY, WELL DOWN
wsbn STRONG BUY, DOWN
nipt strong buy, DOWN

...the list goes on

[gooosed] 08/11/2016 12:56

gnnmartin & small crow - thanks for your posts.

[small crow] 08/11/2016 11:55

FYI, there are about 70,000 total IVF treatments per year in UK.

[gnnmartin] 08/11/2016 11:45

I heard a bit about the assisted reproduction at the AGM. In vitro fertilised eggs are allowed to progress until they have divided into (IIRC) about 20 to 30 cells. Two or three cells are then removed and inspected to assess whether the cell cluster will develop successfully into an embryo. Dr.Denman confirmed that, astonishingly, removal of a few cells does not seem to harm the developing embryo, and the removed cells can be tested to see (for example) if they contain the full set of genes.

Again, I forget how many in vitro fertilisations there are per year, perhaps the foils that Tim referenced will say. It sound like a good further business line if NIPT can show that they can demonstrate the viability of the cell cluster more quickly and more effectively than current methods.

Still, while that is very promising, it is a future possibility. The patent dispute trumps everything for now.

[timbo003] 05/11/2016 11:03

The slide set from the Premaitha presentation at the ShareSoc Leeds event earlier this week are now available here:

[twix386] 04/11/2016 08:01

fine line between dreamer and fantasist with your track record, but delighted to talk again in a mere few weeks then! lol

[ngen yap] 04/11/2016 07:53

Hi DavidLloyd, good to se you here. It's been a while since we met on a BB! I am well and hope you are too. I do still hold the Bartercard shares in my nominee account but have not tracked the progress of the company. I seem to vaguely recollect there was another share restructure and possible exit for us minority shareholders, but must confess I didn't action. Let's hope our investment choice here reaps rewards. I have been here since Vialogy days but have accummulated quite significantly post reversal to date. Good luck.

Twix, you got to dream! Without dreams, there is no ambition. Without ambition, there is no hope. Without hope, we might as well sell up. Here's to dreaming :-) Talk again when it's 20p.

[davidlloyd] 03/11/2016 17:21

Ngen Yap,
Our investment choices appear to once again converge it seems. Trust all is well with you and your investments are proving profitable. Do you still hold paper Bartercard? If yes, have you had any feedback from he company at all? Nothing on my side.....

Questioningly,

DL

[small crow] 03/11/2016 15:36

A year old but an encouraging reminder:

The global non-invasive prenatal testing (NIPT) market was valued at $563.4 million in 2014, and it is expected to grow with a CAGR of 17.6% during the period 2015 - 2020. The global NIPT market is growing, due to increasing healthcare expenditure. The average maternal age is increasing in high income countries, due to changing pattern of employment, education and marriage, and increasing cost of raising a child. The increase in average maternal age is resulting in the growth of the global NIPT market.

hxxps://www.psmarketresearch.com/press-release/nipt-market

More optimistically:

Affymetrix in the fall inked a partnership with Ariosa in the noninvasive prenatal test sector, which Witney (NB Affymetrix CEO) said was a potential $4.8 billion market by 2018. Ariosa is using Affy's Axiom-384HT format as its platform of choice for its Harmony NIPT, but Witney noted during his presentation that Affy is developing a version of its GeneTitan instrument for a distributed form of the Harmony test. In December, Roche announced plans to acquire Ariosa.

hxxps://www.genomeweb.com/business-news/jp-morgan-healthcare-conference-day-two-thermo-fisher-scientific-affymetrix-danaher

[alphapig] 03/11/2016 15:21

The 500k's obviously sells yesterday and I think there was one today? Clear that overhang baby. All smoke and mirrors by mm's RE the 500's, borders on deception (nothing new there).

[twix386] 03/11/2016 14:06

Ngen,Excluding Xmas week and fwd, you expect to see 20p within the next 6 weeks!Always possible, but more likely your usual dreaming

[hjb1] 03/11/2016 12:47

that's from yesterday 2nd Nov

[deanroberthunt] 03/11/2016 12:37

and another 500k at 9.5

[hjb1] 03/11/2016 12:09

yes, so you KEEP saying, over and over and over and over! and talking of NO substance, well you should know ... lol!